<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>StockPreacher &#187; medical industry</title>
	<atom:link href="http://stockpreacher.com/tag/medical-industry/feed/" rel="self" type="application/rss+xml" />
	<link>http://stockpreacher.com</link>
	<description>Penny Stock Blog, Small cap Micro Stock Alert and Stock Investment Tips</description>
	<lastBuildDate>Fri, 20 Nov 2009 11:37:12 +0000</lastBuildDate>
	<generator>http://wordpress.org/?v=2.8.4</generator>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<xhtml:meta xmlns:xhtml="http://www.w3.org/1999/xhtml" name="robots" content="noindex" />
		<item>
		<title>Trading Outlook for Cell Therapeutics Inc. (CTIC)</title>
		<link>http://stockpreacher.com/2009/08/18/trading-outlook-for-cell-therapeutics-inc-ctic/</link>
		<comments>http://stockpreacher.com/2009/08/18/trading-outlook-for-cell-therapeutics-inc-ctic/#comments</comments>
		<pubDate>Wed, 19 Aug 2009 02:48:41 +0000</pubDate>
		<dc:creator>boss</dc:creator>
				<category><![CDATA[Stock Profiles]]></category>
		<category><![CDATA[CTIC]]></category>
		<category><![CDATA[medical industry]]></category>
		<category><![CDATA[penny stock blog]]></category>
		<category><![CDATA[small cap trading]]></category>

		<guid isPermaLink="false">http://stockpreacher.com/?p=2501</guid>
		<description><![CDATA[Cell Therapeutics Inc. (Nasdaq: CTIC)

 
Cell Therapeutics Inc. (CTIC) is a biopharmaceutical company engaged in the development and commercialization of oncology drug therapies for the treatment of cancer. Its portfolio of trial therapies include phase III candidate drug therapy Pixantrone, for the treatment of non-Hodgkin&#8217;s lymphoma; phase II drug Brostallicin, for the treatment of sarcoma; [...]]]></description>
		<wfw:commentRss>http://stockpreacher.com/2009/08/18/trading-outlook-for-cell-therapeutics-inc-ctic/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Biggest Shift in US Health Care May Emerge in 45-Day Sprint</title>
		<link>http://stockpreacher.com/2009/06/22/biggest-shift-in-us-health-care-may-emerge-in-45-day-sprint/</link>
		<comments>http://stockpreacher.com/2009/06/22/biggest-shift-in-us-health-care-may-emerge-in-45-day-sprint/#comments</comments>
		<pubDate>Mon, 22 Jun 2009 15:51:48 +0000</pubDate>
		<dc:creator>boss</dc:creator>
				<category><![CDATA[Uncategorized]]></category>
		<category><![CDATA[1965]]></category>
		<category><![CDATA[Barack Obama]]></category>
		<category><![CDATA[Democratic]]></category>
		<category><![CDATA[economy]]></category>
		<category><![CDATA[finance]]></category>
		<category><![CDATA[Harvard University]]></category>
		<category><![CDATA[health benefits]]></category>
		<category><![CDATA[health care]]></category>
		<category><![CDATA[medical industry]]></category>
		<category><![CDATA[medicare]]></category>
		<category><![CDATA[white house]]></category>

		<guid isPermaLink="false">http://stockpreacher.com/?p=1957</guid>
		<description><![CDATA[ 
The largest expansion of US health care since the creation of Medicare in 1965 may emerge from legislation designed to reshape the medical industry and change how Americans receive and pay for care.  Congress today begins crafting legislation that Democratic leaders plan to push through both chambers by their August recess. The measure [...]]]></description>
		<wfw:commentRss>http://stockpreacher.com/2009/06/22/biggest-shift-in-us-health-care-may-emerge-in-45-day-sprint/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
